1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
45 
twice* for further elaboration before conplete approval 
by the membership was given. 
Connittee nenbers recognize that such research 
nay involve biohazards and are nindful of the public 
concern on reconbinant DNA . Further, it is well recog- 
nized that it is essential that all research involving 
the use of reconbinant DNA nolecules be conducted in a 
responsible nanner, adhering to safety precautions and 
conditions designed to protect laboratory workers, the 
general public, and our environment. 
Earlier this year, I had the opportunity to 
attend a biosafety connittee meeting at the Scripps 
Clinic and Research Foundation at La Jolla, California. 
The Scripps biosafety connittee had a similar profile, 
and was extremely effective and nonpartial in their 
deliberations. I am certain, without reservation, that 
institutional biosafety committees can be relied upon 
for authoritative and proper implementation of the 
guidelines, provided tnose committees are required to be 
organized and established according to the recommendations 
of the NIH. 
Lastly, some questions have arisen at the 
Agricultural Research Center concerning certain interpre- 
tations of the revised guidelines that relate to specific 
scientific and research containment procedures and 
[ 137 ] 
